Literature DB >> 6530540

Obesity, alcohol consumption and blood pressure in Australian men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study.

S W MacMahon, R B Blacket, G J Macdonald, W Hall.   

Abstract

The associations of obesity and alcohol consumption with blood pressure and the prevalence of hypertension were studied in 5550 male and female subjects aged 25 to 64 years, surveyed in the National Heart Foundation of Australia 1980 Risk Factor Prevalence Study. Body mass index was significantly and independently associated with blood pressure levels in both sexes. A maximum of 30% of hypertension in the study population could be attributed to overweight. The association between body mass index and hypertension was greater in men under 45 years in whom a maximum of 60% of hypertension could be attributed to overweight. In both men and women receiving antihypertensive treatment, body mass index was positively associated with blood pressure. Overweight hypertensives were less likely to achieve normal blood pressure on treatment. Alcohol consumption was significantly and independently associated with blood pressure levels in males. A similar trend in females failed to reach statistical significance because of the lesser consumption of alcohol by females. A maximum of 11% of hypertension in males and 1% in females could be attributed to alcohol consumption. These estimates were reduced when age and body mass were taken into account.

Entities:  

Mesh:

Year:  1984        PMID: 6530540     DOI: 10.1097/00004872-198402000-00015

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  20 in total

Review 1.  The medical risks of obesity.

Authors:  F Xavier Pi-Sunyer
Journal:  Obes Surg       Date:  2002-04       Impact factor: 4.129

Review 2.  Cardiovascular effects of alcohol.

Authors:  D M Davidson
Journal:  West J Med       Date:  1989-10

3.  Serial study on the association between body mass index and hypertension in rural Japanese.

Authors:  Jingmei Jiang; Takao Kitano; Masahiro Shono; Junji Wakamiya; Makoto Futatsuka
Journal:  Environ Health Prev Med       Date:  2003-07       Impact factor: 3.674

Review 4.  Recommendations of the Canadian Consensus Conference on Non-Pharmacological Approaches to the Management of High Blood Pressure, Mar. 21-23, 1989, Halifax, Nova Scotia.

Authors:  A Chockalingam; D Abbott; M Bass; R Battista; R Cameron; J de Champlain; C E Evans; J Laidlaw; B L Lee; L Leiter
Journal:  CMAJ       Date:  1990-06-15       Impact factor: 8.262

Review 5.  Value of non-drug treatment and drug treatment in hypertension.

Authors:  L J Beilin
Journal:  Drugs       Date:  1988       Impact factor: 9.546

6.  Randomized trial of perindopril, enalapril, losartan and telmisartan in overweight or obese patients with hypertension.

Authors:  Sergey V Nedogoda; Alla A Ledyaeva; Elena V Chumachok; Vera V Tsoma; Galina Mazina; Alla S Salasyuk; Irina N Barykina
Journal:  Clin Drug Investig       Date:  2013-08       Impact factor: 2.859

7.  Lifestyle modifications to prevent and control hypertension. 3. Recommendations on alcohol consumption. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.

Authors:  N R Campbell; M J Ashley; S G Carruthers; Y Lacourcière; D W McKay
Journal:  CMAJ       Date:  1999-05-04       Impact factor: 8.262

8.  A retrospective cohort study on obesity and hypertension risk among Korean adults.

Authors:  Sung-Hee Lee; Young-Sik Kim; Sung Sunwoo; Bong-Yul Huh
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

Review 9.  Insulin resistance and the sympathetic nervous system.

Authors:  Brent M Egan
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

Review 10.  Alcohol-induced hypertension: Mechanism and prevention.

Authors:  Kazim Husain; Rais A Ansari; Leon Ferder
Journal:  World J Cardiol       Date:  2014-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.